DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Topical Antibiotics and Intravitreous Injections

Information source: Stanford University
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Intravitreous; Injections

Intervention: gatifloxacin (Drug)

Phase: Phase 4

Status: Completed

Sponsored by: Stanford University

Official(s) and/or principal investigator(s):
Christopher Ta, MD, Principal Investigator, Affiliation: Stanford University


Evaluation of efficacy of topical preoperative antibiotics in patients undergoing intravitreous injections.

Clinical Details

Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator)

Primary outcome:

Conjunctival Bacterial Flora

Positive Culture


Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.


Inclusion Criteria:

- intravitreous injection

Exclusion Criteria:

- antibiotic use

Locations and Contacts

Stanford, Stanford, California 94304, United States
Additional Information

Starting date: July 2008
Last updated: May 13, 2014

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017